Home › Funds › ArrowMark Colorado Holdings LLC › ZBIO

ArrowMark Colorado Holdings LLC position in ZBIO

ZENAS BIOPHARMA INC COM · Health Care

ArrowMark Colorado Holdings LLC reported holding 573,318 shares of ZBIO (ZENAS BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$14.6M, representing 0.61% of its reported portfolio and ranking #39 among its reported holdings. ArrowMark Colorado Holdings LLC has disclosed ZBIO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)573.32K sh
Reported value held$14.55M
Portfolio Weight0.61%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ArrowMark Colorado Holdings LLC's ZBIO position evolved

ArrowMark Colorado Holdings LLC first disclosed a stake in ZBIO in Q3 2024 at 300,000 shares (US$5.1M). The position peaked in Q4 2025 at 751,161 shares, worth US$27.3M. Across 8 filings, ArrowMark Colorado Holdings LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 573,318 shares valued at US$14.6M — a reduction of -85,591 shares quarter over quarter.. Notable position changes include a 109% increase in Q4 2024 (shares fell 4% over the following quarter), a 75% increase in Q1 2025 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 300.00K $5.08M New
Q4 2024 627.67K $5.14M Add
Q1 2025 1.10M $8.67M Add
Q2 2025 1.09M $10.60M Hold
Q3 2025 824.67K $18.31M Reduce
Q4 2025 751.16K $27.27M Reduce
Q1 2026 658.91K $12.88M Reduce
Q2 2026 573.32K $14.55M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZBIO and 13F data

ZBIO (ZENAS BIOPHARMA INC COM) is a Health Care company. 68 other funds we track also report a position in ZBIO — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$127.9M), NEA Management Company, LLC (US$102.1M), Enavate Sciences GP, LLC (US$99.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZBIO

All ZBIO fund holders →

FAQ

How long has ArrowMark Colorado Holdings LLC held ZBIO?

ArrowMark Colorado Holdings LLC has disclosed ZBIO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is ArrowMark Colorado Holdings LLC's current position in ZBIO?

As of Q2 2026, ArrowMark Colorado Holdings LLC holds 573.32K shares of ZBIO (ZENAS BIOPHARMA INC COM), valued at $14.55M, representing 0.61% of its reported portfolio and ranking #39.

Has ArrowMark Colorado Holdings LLC been buying or selling ZBIO?

In the latest 13F filing (Q2 2026), ArrowMark Colorado Holdings LLC reduced its position in ZBIO. The position peaked in Q4 2025 at 751.16K shares.

Which other funds hold ZBIO?

Other major institutional holders of ZBIO include SR ONE CAPITAL MANAGEMENT, LP, NEA Management Company, LLC, Enavate Sciences GP, LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.